Medicure (MCUJF) Change in Receivables (2009 - 2026)
Medicure (MCUJF) posted quarterly Change in Receivables of -$654826.7 for Q1 2026, down 212.26% year-over-year from $583319.1 in Q1 2025, and down 54.25% quarter-over-quarter from -$424515.1 in Q4 2025.
Medicure (MCUJF) Change in Receivables (2009 - 2026) Analysis & Trends
Medicure's Change in Receivables history runs 18 years deep, the most recent figure standing at -$654826.7 for Q1 2026.
- In Q1 2026, Change in Receivables fell 212.26% year-over-year to -$654826.7; the TTM figure through Mar 2026 stood at -$1.1 million (down 204.43% YoY), while the FY2025 annual figure was $162468.8, up 48.29% from the prior year.
- Change in Receivables for Q1 2026 stood at -$654826.7, down from -$424515.1 in the prior quarter.
- The five-year high for Change in Receivables was $595879.5 in Q2 2024, with the low at -$1.1 million in Q1 2022.
- The 5-year median for Change in Receivables is -$171204.4 (2022), against an average of -$133207.4.
- Peak annual rise in Change in Receivables reached 455.44% in 2025, while the deepest fall reached 3388.37% in 2025.
- Medicure's Change in Receivables stood at -$218522.7 in 2022, then surged by 326.56% to $495076.9 in 2023, then plunged by 102.46% to -$12169.4 in 2024, then slumped by 3388.37% to -$424515.1 in 2025, then slumped by 54.25% to -$654826.7 in 2026.
- Business Quant data shows MCUJF's Change in Receivables at -$654826.7 in Q1 2026, -$424515.1 in Q4 2025, and $440340.8 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Medicure | 97.06 Mn | 95.93 Mn | 2.57 Mn | -654,826.71 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -654,826.71 |
| Mar 31, 2026 | -654,826.71 |
| Dec 31, 2025 | -424,515.08 |
| Dec 31, 2025 | -424,515.08 |
| Sep 30, 2025 | 440,340.81 |
| Sep 30, 2025 | 440,340.81 |
| Jun 30, 2025 | -450,348.60 |
| Jun 30, 2025 | -450,348.60 |
| Mar 31, 2025 | 583,319.09 |
| Mar 31, 2025 | 583,319.09 |
| Dec 31, 2024 | -12,169.44 |
| Dec 31, 2024 | -12,169.44 |
| Sep 30, 2024 | -123,886.03 |
| Sep 30, 2024 | -123,886.03 |
| Jun 30, 2024 | 595,879.55 |
| Jun 30, 2024 | 595,879.55 |
| Mar 31, 2024 | -355,472.23 |
| Mar 31, 2024 | -355,472.23 |
| Dec 31, 2023 | 495,076.95 |
| Dec 31, 2023 | 495,076.95 |